Abstract
Radiofrequency ablation, with the HALO ablation technology, is a very specific type of ablation, in which the energy is released in a precise and highly controlled manner, to treat Barrett’s esophagus.
It’s safety and high efficacy rate have been shown in more than 70 peer-reviewed publications.
Recently the HALO system has also shown to accrue a considerable cost-saving benefit and a higher quality of life, compared to endoscopic surveillance, in all Barrett’s stages and to surgical intervention in high grade dysplasia patients.
Currently there are still several topics to investigate, as the optimal management strategy of patients once ablated and new data will be available in the near future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shaheen NJ, Sharma P, Overholt BF et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360(22):2277–2288
Fleischer DE, Overholt BF, Sharma VK et al (2010) Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 42:781–789
Shaheen NJ et al (2011) Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 141:460–468
Inadomi JM, Somsouk M, Madanick RD, Thomas JP, Shaheen NJ (2009) A cost-utility analysis of ablative therapy for Barrett’s esophagus. Gastroenterology 136:2101–2114
Das A, Wells C, Kim HJ, Fleischer DE, Crowell MD, Sharma VK (2009) An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett’s esophagus. Endoscopy 41:400–408
Pohl H, Sonnenberg A, Strobel S, Eckardt A, Roesch T (2009) Endoscopic versus surgical therapy for early cancer in Barrett’s esophagus: a decision analysis. Gastrointest Endosc 70:623–631
Boger PC, Turner D, Roderick P, Patel P (2010) A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barrett’s esophagus. Aliment Pharmacol Ther 32:1332–1342
American Gastroenterological Association (2011) Medical position statement on the management of Barrett’s esophagus. Gastroenterology 140:1084–1091
Sharma P, Falk GW, Weston AP et al (2006) Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin Gastroenterol Hepatol 4:566–572
Wang C, Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 97:1888–1895
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Rancati, F., Meroni, E. (2012). Cost-Effectiveness of Radiofrequency Ablation for Barrett’s Esophagus. In: Bonavina, L. (eds) Innovation in Esophageal Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2469-4_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-2469-4_7
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2468-7
Online ISBN: 978-88-470-2469-4
eBook Packages: MedicineMedicine (R0)